A股異動丨玉禾田(300815.SZ)大漲7%盤中再創新高 首季淨利預增超1倍
格隆匯4月9日丨次新股玉禾田(300815.SZ)高開上漲,盤初一度衝高超9%再創新高。現報138.58元,漲7.19%,暫成交1.89億元,最新總市值191.8億元。玉禾田預計一季度淨利潤為1.3億-1.48億元,同比增長125%-155%,本期公司承接的新項目增加了營業收入。天風證券點評稱,20Q1預計淨利同比增125%-155%超預期,城市綜合服務商打造標杆加速成長,上調20-21年盈利預測,給予買入評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.